Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.20.2
Shareholders' Deficit (Tables)
 6 Months Ended
Jun. 30, 2020
Equity [Abstract]
Schedule of nonvested activity
Number of
Non-vested
Shares		 Weighted
Average
Grant Date
Fair Value
Non-vested, December 31, 2019 17,675,299 $ 0.23
Granted 7,450,000 0.04
Shares vested (1,273,373 ) (0.41 )
Non-vested, June 30, 2020 23,851,926 $ 0.16
Schedule of stock option activities
Number of Options Weighted Average Exercise Price Weighted
Average
Remaining
Contractual Term (Years)		 Aggregate Intrinsic
Value
Balance Outstanding, December 31, 2019 8,445,698 $ 0.40
Granted - -
Forfeited - -
Balance Outstanding, June 30, 2020 8,445,698 $ 0.40 5.69 $ 0
Exercisable, June 30, 2020 8,152,547 $ 0.41 5.63 $ 0
Schedule of warrant activities
Number of Warrants Weighted Average Exercise Price Weighted
Average
Remaining
Contractual
Term (Years)		 Aggregate Intrinsic
Value
Balance Outstanding December 31, 2019 2,050,000 $ 0.10 - $ -
Granted 288,750 0.003
Cancelled - -
Balance Outstanding June 30, 2020 2,338,750 $ 0.04 4.23 $ 11,848
Exercisable, June 30, 2020 2,338,750 $ 0.04 4.23 $ 11,848